KLKBY vs LGND
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
KLKBY · KUALA LUMPUR KEPONG BERHAD ADR(CNV 1 ORD MYR1$5.03 ▲ 0.00%
LGND · Ligand Pharmaceuticals$306.20 ▲ 2.41%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- KLKBY +63.2%
- LGND +46.3%
Head to head
| Metric | KLKBY | LGND |
|---|---|---|
| Price | $5.03 | $306.20 |
| Change today | ▲ 0.00% | ▲ 2.41% |
| Market cap | $6.13B | $6.12B |
| Return, 3 months | -8.6% | +3.6% |
| Return, year to date | +157.7% | +62.0% |
| Return, 1 year | +63.2% | +51.2% |
| P/E (TTM) | – | 123.0 |
| P/B | 0.2 | 6.4 |
| P/E percentile vs own 5y | – | 100th |
| Dividend yield | 2.99% | – |
| Revenue growth (YoY, latest qtr) | – | -31.8% |
| Net profit growth (YoY) | – | -124.3% |
| Gross margin | – | 95.2% |
| Operating margin | – | 14.4% |
| Net margin | – | 20.3% |
| Return on equity | – | 5.4% |
| Analyst target vs. price | – | +19.4% |
| Analyst buy share | – | 100% |
| RSI (14) | 49 | 50 |
| 30-day volatility | 38.3% | 39.1% |
| Max drawdown, 1 year | -60.9% | -14.7% |
| Trend read | Leaning bullish | Leaning bullish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- KLKBY is the largest of the group by market value.
- KLKBY has returned the most over the past year.
- KLKBY has been the calmest stock over the last 30 days.